Comparing Efficacy of Postoperative Oral Antibiotic Use in Trans-Oral Thyroidectomy (POTO)

September 26, 2017 updated by: Jin Wook Yi, Seoul National University Hospital

Comparing Efficacy of Postoperative Antibiotic Use in Transoral Thyroidectomy: a Prospective Randomized Controlled Trial Study

Transoral endoscopic thyroid surgery is a emerging surgical technique for thyroid surgery. This study to investigate the need for postoperative antibiotics in transoral endoscopic thyroid surgery.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

To prevent possible infection from the oral cavity flora, most surgeons prescribe postoperative oral antibiotics more than 3 to 7 days after surgery. Currently, there's no clinical evidence that postoperative oral antibiotics is necessary or not in transoral endoscopic thyroid surgery. The investigator will conduct randomization after transoral thyroid surgery with two groups : postoperative oral antibiotics group versus no oral antibiotics group.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who planned to Transoral endoscopic thyroidectomy
  • Age between 20 to 70
  • Voluntarily consenting to the study and study agreement
  • No local invasion or distant metastasis
  • Normal vocal cord function in laryngoscopic exam
  • No significant abnormalities in preoperative laboratory tests

Exclusion Criteria:

  • Take aspirin or antiplatelet drugs within 7 days before admission
  • Uncontrolled hypertension, diabetes, chronic renal failure, or coagulation disease
  • History of cardiovascular disease (angina pectoris, heart failure, myocardial infarction, history of coronary artery disease, stroke, transient ischemic attack)
  • Substance abuse and alcohol abuse
  • History of esophageal and airway diseases
  • Patient was participated in other clinical trials within 30 days
  • History of neck irradiation or surgery
  • History of drug allergies
  • Pregnant or lactating women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Postop antibiotics group
Prescribe Amoxicillin Clavulanate
Per-oral "Amoxicillin Clavulanate" Given or Non-given, after surgery
No Intervention: No postop antibiotics
Do not prescribe Amoxicillin Clavulanate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
"CDC 1992 SSI table" score
Time Frame: Postoperative 1 day
Clinical evidence of Surgical Site Infection
Postoperative 1 day
CBC, CRP
Time Frame: Postoperative 1 day
Laboratory test
Postoperative 1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of "CDC 1992 SSI table" score
Time Frame: Compare the CDC 1992 SSI table score between postoperative 1 day and 2 day/2 weeks.
Clinical evidence of Surgical Site Infection
Compare the CDC 1992 SSI table score between postoperative 1 day and 2 day/2 weeks.
Change of CBC, CRP
Time Frame: Compare the CBC, CRP between postoperative 1 day and 2 day
Laboratory test
Compare the CBC, CRP between postoperative 1 day and 2 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 4, 2017

Primary Completion (Anticipated)

September 3, 2018

Study Completion (Anticipated)

December 3, 2018

Study Registration Dates

First Submitted

September 20, 2017

First Submitted That Met QC Criteria

September 26, 2017

First Posted (Actual)

September 28, 2017

Study Record Updates

Last Update Posted (Actual)

September 28, 2017

Last Update Submitted That Met QC Criteria

September 26, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgical Wound Infection

Clinical Trials on Amoxicillin Clavulanate

Subscribe